List of works - Xiaoyan Si

Abivertinib in patients with T790M-positive advanced NSCLC and its subsequent treatment with osimertinib

scientific article published on 14 January 2020

Clinical diagnosis and treatment of immune checkpoint inhibitor-associated adverse events in the digestive system

scientific article published on 28 February 2020

Clinical diagnosis and treatment of immune checkpoint inhibitor-associated pneumonitis

scientific article published on 24 November 2019

Clinical diagnosis and treatment of immune checkpoint inhibitors-related endocrine dysfunction

scientific article published on 11 February 2020

Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor-related hematological adverse events

scientific article published on 03 February 2020

Clinical diagnosis and treatment recommendations for ocular toxicities of targeted therapy and immune checkpoint inhibitor therapy

scientific article published on 04 February 2020

Clinical manifestation and management of immune checkpoint inhibitor-associated cardiotoxicity

scientific article published on 17 December 2019

Clinical recommendations on diagnosis and treatment of immune checkpoint inhibitor-induced renal immune-related adverse events

scientific article published on 30 March 2020

EGFR T790M detection in formalin-fixed paraffin-embedded tissues of patients with lung cancer using RNA-based in situ hybridization: A preliminary feasibility study

scientific article published on 13 August 2019

Genomic characteristics of driver genes in Chinese patients with non-small cell lung cancer

scientific article published on 09 December 2020

Histologic transformation of lung cancer during pembrolizumab therapy: A case report

scientific article published on 16 January 2020

Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303

scientific article published on 21 January 2019

Management of immune checkpoint inhibitor-related adverse events: A review of case reports

scientific article published on 22 January 2020

Management of immune checkpoint inhibitor-related dermatologic adverse events

scientific article published on 09 December 2019

Management of immune checkpoint inhibitor-related rheumatic adverse events

scientific article published on 24 November 2019

Nimotuzumab combined with chemotherapy as first-line treatment for advanced lung squamous cell carcinoma

scientific article published on 19 June 2018

Opportunistic infections complicating immunotherapy for non-small cell lung cancer

scientific article published on 20 April 2020

Recommendation for the diagnosis and management of immune checkpoint inhibitor related infections

scientific article published on 22 January 2020

Relationship between intestinal flora structure and metabolite analysis and immunotherapy efficacy in Chinese NSCLC patients

scientific article published on 23 April 2020

Relationship between the efficacy of immunotherapy and characteristics of specific tumor mutation genes in non-small cell lung cancer patients

scientific article published on 27 April 2020

Single-center study to determine the safety and efficacy of CT-707 in Chinese patients with advanced anaplastic lymphoma kinase-rearranged non-small-cell lung cancer

scientific article published on 17 March 2020

Successful treatment of pulmonary inflammatory myofibroblastic tumor with platinum-pemetrexed: The first report of two cases

scientific article published on 03 June 2020

Treatment with or without bevacizumab as a first-line and maintenance therapy for advanced non-squamous non-small cell lung cancer: A retrospective study

scientific article published on 14 May 2020

Use of glucocorticoids in the management of immunotherapy-related adverse effects

scientific article published on 06 September 2020

List of works by Xiaoyan Si